U.S. Markets close in 13 mins

Why Roche Cancer Trial Is Kick In The Teeth For Dow Stock Merck

ALLISON GATLIN
Why Roche Cancer Trial Is Kick In The Teeth For Dow Stock Merck

Roche is now a real competitor with a potential first treatment in advanced lung cancer, an analyst said Monday.